No Data
Earnings Preview: CATX to Report Financial Results Post-market on November 12
$Perspective Therapeutics(CATX.US)$ is scheduled to release its financial results post-market on November 12 ET. Earnings PreviewAnalysts estimate $Perspective Therapeutics(CATX.US)$ to post revenue
Perspective Therapeutics to Provide Business Highlights and Report Third Quarter 2024 Financial Results
Positive Outlook For Novartis As Company Capitalizes On Growing Treatment Opportunities, Analyst Highlights
Perspective Therapeutics to Participate in Upcoming Investor Conferences in November
UBS Launches SMID Cap Biotechs With Cancer, Autoimmunity in Focus
Wedbush Maintains Perspective Therapeutics(CATX.US) With Buy Rating, Cuts Target Price to $20
No Data
No Data